Multiple primary malignancies in head and neck cancer

Archives of Otolaryngology--head & Neck Surgery
A H ShikhaniM E Johns

Abstract

Multiple primary (MP) malignancies were found in 9.7% of 1961 patients with primary head and neck cancer diagnosed at The Johns Hopkins Hospital, Baltimore, during the years 1975 to 1985. The index tumors were divided into six main groups. Out of the 190 MP malignancies, 46.9% were synchronous and 53.1% were metachronous. Seventy-four percent of MP lesions were noted during the first year after diagnosis of the index primary tumor. Patients with an index tumor in the upper aerodigestive tract had a significantly increased risk of developing a second cancer in the head and neck area. This risk was 5.94 for the oral cavity, 6.98 for the pharynx, 3.57 for the larynx, and 7.02 for the esophagus. Patients with an index tumor in the salivary gland or the thyroid gland had, respectively, a 3.59 and a 7.38 higher risk than the general population of developing a second tumor. Efforts aimed at improving the survival of patients with head and neck cancer must incorporate strategies for the prevention, early detection, and treatment of MP neoplasms.

Citations

Sep 13, 2001·Radiographics : a Review Publication of the Radiological Society of North America, Inc·L H LoweM Hernanz-Schulman
May 13, 2014·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Mohammed QaisiRobert Ord
Sep 17, 1998·The Laryngoscope·C G Shores, W G Yarbrough
Nov 1, 1995·Critical Reviews in Oncology/hematology·C Scully, R P Ward-Booth
May 1, 1996·American Journal of Otolaryngology·B C StackJ N Endicott
Sep 1, 1990·The Journal of Laryngology and Otology·M MiyaguchiS Kitaoku
Jan 1, 1997·International Urology and Nephrology·A S OzdamarA Gökalp
Jan 3, 2001·Clinics in Dermatology·S Silverman, P B Sugerman
Sep 17, 2013·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Wei-Ming LaiLuo-Ping Ger
Feb 1, 1994·International Journal of Cancer. Journal International Du Cancer·A JovanovicI van der Waal
Aug 1, 1991·Journal of Surgical Oncology·M SteinA Kuten
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P M TeoP J Johnson
Jun 26, 2010·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Jessica E Omlie, Ioannis G Koutlas
Feb 15, 2008·Auris, Nasus, Larynx·Naoki ShimizuRyuji Okamura
Oct 1, 1993·European Journal of Cancer. Part B, Oral Oncology·Y Jin, F Mertens
Jan 1, 1994·European Journal of Cancer. Part B, Oral Oncology·A S Jones
Jul 1, 1994·European Journal of Cancer. Part B, Oral Oncology·A JovanovicI van der Waal
May 13, 1998·The British Journal of Oral & Maxillofacial Surgery·R Crosher, R McIlroy
Feb 1, 1989·Journal of Surgical Oncology·C KotwallU Rao
Sep 5, 2006·Auris, Nasus, Larynx·Noriko WatanabeTakeshi Kubo
Mar 1, 1988·Head & Neck Surgery·A R ShahaY P Krespi
Sep 13, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Stefan WelzClaus Belka
Dec 17, 2014·Oral Oncology·Yumi MochizukiKen Omura
Aug 31, 1999·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·H MiyazatoS Koja
Feb 1, 1992·The Annals of Otology, Rhinology, and Laryngology·B H HaugheyJ Harvey
Feb 1, 1992·The Annals of Otology, Rhinology, and Laryngology·C K Bacon, R A Hendrix
Dec 1, 1995·The Annals of Otology, Rhinology, and Laryngology·E M Sturgis, R H Miller
Oct 1, 1992·European Journal of Cancer. Part B, Oral Oncology·N de VriesU Pastorino
Oct 1, 1989·The British Journal of Oral & Maxillofacial Surgery·R J Carr, J D Langdon
Sep 1, 1989·International Journal of Radiation Oncology, Biology, Physics·J S CooperJ D Cox
Nov 1, 1987·The Annals of Otology, Rhinology, and Laryngology·M A StrigenzT W Grossman
Oct 30, 2003·British Journal of Cancer·C RubinoM Schlumberger
Nov 22, 2019·Head & Neck·Andrés Coca-PelazAlfio Ferlito
Jul 1, 1990·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·J T LarsonH A Fattah

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Fangcen GuoYang Ke
© 2021 Meta ULC. All rights reserved